Ama Umesi

发表

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.

Douglas J. Taylor, S. Lamola, D. Goldblatt, 2021, The Lancet. Infectious diseases.

Enhancement of cytokine‐driven NK cell IFN‐γ production after vaccination of HCMV infected Africans

S. Moore, E. Riley, R. Wegmuller, 2017, European journal of immunology.

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial.

S. Lamola, D. Weiner, D. Goldblatt, 2019, Vaccine.

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambiaâ€”Results of a phase 1/2 randomized, double-blinded, controlled trial

S. Lamola, D. Weiner, D. Goldblatt, 2019 .

COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP)

B. Edem, M. Calnan, C. Onwuchekwa, 2021, Trials.

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia

W. Weldon, R. Sutter, D. Jeffries, 2021, The Lancet. Global health.

Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.

M. Niedrig, K. Brown, A. Bandyopadhyay, 2016, The Lancet. Global health.

Meningococcal ACWYX conjugate vaccine in 2–29 year-olds in Mali and Gambia

S. Lamola, Evangelos Simeonidis, Pankaj Sharma, 2023, The New England journal of medicine.

Enhancement of cytokine‐driven NK cell IFN‐γ production after vaccination of HCMV infected Africans

Ebrima S. Touray, M. Goodier, A. Darboe, 2017, European journal of immunology.